**Specifications Table**Subject areaBiologyMore specific subject areaToxicogenomicsType of dataGenomic DataHow data was acquiredMicroarrayData formatRaw: TXT files; normalized data: TXT filesExperimental factorsTK6 cells, a human lymphoblastoid cell line were obtained from American Type Culture Collection (ATCC\# CRL-8015; ATCC, Manassas, VA, USA). Briefly, cells were cultured and maintained in RPMI 1640 medium containing 10% heat inactivated horse serum, in addition to 0.1% pluronics, sodium pyruvate and antibiotics (penicillin at 20 units/ml and streptomycin at 20 µg/ml) at 37±1 °C and 6±1% CO~2~ in air. Immediately prior to chemical exposure, cells were seeded at a density of 4 (±0.5)× 10^5^ cells/ml in twelve-well plates with a final volume of 3 ml per well. For chemicals requiring metabolic activation, exposures were conducted in the presence of 1% 5,6 benzoflavone-/phenobarbital-induced rat liver S9 (BF/PB-induced S9) (Moltox, Boone, NC, USA) with NADPH generating system cofactors.Experimental featuresTranscriptome measurements were performed using a two-color dye swap design [@bib4].Data source locationWashington, D.C., USA and Ottawa, Ontario, CanadaData accessibilityNational Centre for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) database Accession: GSE58431 and GSE51175<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58431><http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51175>

Value of the data•The data were integral in developing a genomic biomarker-based approach to predict genotoxicity in human TK6 cells based on expression profiles induced by 28 chemicals that span a variety of well-defined genotoxic and non-genotoxic modes of action.•The data also demonstrate that the use of S9 does not alter gene expression changes used to classify genotoxicity in TK6 cells, expanding on the test agents applied using the biomarker.•The biomarker and these original training data sets can serve as a basis for testing new chemicals for genotoxicity using DNA microarray and other genomics platforms, in other cell types, and potentially in alternative organisms.•The database can be expanded to develop signatures that delve into more detailed genotoxic modes of action (e.g., signatures for cross-linking agents or other types of DNA lesions represented in the training set).•We anticipate that the importance of toxicogenomics studies in chemical risk assessment will continue to increase in the coming years and believe that the rate at which this occurs will be highly dependent upon ensuring public availability of these very powerful datasets sets and tools such as those described.

1. Data {#s0005}
=======

The training set (GSE58431) consists of transcriptional changes in TK6 cells following exposure to a diverse set of model agents that include: DNA alkylators, DNA strand breaking agents, topoisomerase inhibitors, nucleotide antimetabolites, endoplasmic reticulum (ER) stressors, energy metabolism inhibitors, histone deacetylase (HDAC) inhibitors, microtubule inhibitors, and heavy metals. From these data, a panel of 65 genes was identified that could accurately classify toxicants as genotoxic or non-genotoxic.

As TK6 cells are not metabolically competent, the test data (GSE51175) examine the utility of the biomarker for use with chemicals requiring metabolic activation in order to broaden the biomarker׳s application [@bib1]. Here, chemical exposures were conducted in the presence of rat liver S9.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

Transcriptome measurements were performed using a two-color dye swap design [@bib4]. For each agent, cyanine-3 and cyanine-5 labeled cRNA for treated and untreated samples were co-hybridized to two Agilent oligonucleotide microarrays. One microarray was hybridized with the treated cyanine-3 labeled cRNA co-hybridized with the untreated cyanine-5 labeled cRNA. The second slide was hybridized with the treated and untreated samples having the reversed cyanine-3 and cyanine-5 labeling. A summary of the workflow for the subsequent steps are presented as [Fig. 1](#f0005){ref-type="fig"}.

2.2. Hybridization and data quantification {#s0020}
------------------------------------------

Hybridization and washing was performed according to the manufacturer׳s protocol. Arrays were scanned with an Agilent DNA microarray scanner. Feature Extraction (Version 9.1; Agilent) was used to quantify the scanned images for the 4x44k platform, to calculate the processed signal intensity and to estimate the log ratios (log 10). Similarly for the 8x60k platform, Agilent Feature Extraction software (version 11.0.1.1) was used for quantification of the generated image files, to generate the QC reports as well as the processed signal intensity and to estimate the log ratios (log 10).

2.3. Data processing and normalization {#s0025}
--------------------------------------

Microarray annotation files for the Agilent human 1x44k (eArray 1x44K human_20120130.txt), 4x44k (eArray 4x44K human_20120130.txt), 4x44k version 2 (eArray 4x44K human_v2_20120130.txt), 8x60k (eArray 8x60K human_20120411.txt), and the 8x60k version 2 (eArray 8x60K human_v2_20120628.txt) platform were obtained from eArray (<https://earray.chem.agilent.com/earray/>). These annotation files were read into the R statistical environment [@bib6]. All unique Agilent probe ids from these platforms were used to create an annotation file using the Probes.R script named Agilent annotation.txt. This annotation file was then merged with the Feature Extraction data files to collapse the probe ID׳s to the gene symbol.

Agilent Feature Extraction.TXT files were read into the R environment using the Read.R script. This R script extracts the normalized relative intensities, merges the Agilent annotation.txt file using the probe ids and uses the weighted mean to average the probes with multiple gene symbols. Once all the data files have been processed, the individual data sets were then merged together using the gene symbol. The data were merged together such that the dye swaps were in adjacent columns. The dye swaps were then averaged and the processed data file named LogRatio.txt was written out to disk.

2.4. Development of the TGx-28.65 genotoxicity classifier {#s0030}
---------------------------------------------------------

The original 65-gene signature, as published in Li et al. [@bib5], referred to as TGx-28.65 (28 refers to the use of 28 chemicals in the training set) was developed using the nearest shrunken centroids approach [@bib7]. Gene expression data were exported from Rosetta Resolver based on Entrez Gene Identifiers. The data were then read into the R statistical environment employing the pamr package [@bib3]. The standardized centroids to predict whether an agent is genotoxic or not (either directly or indirectly) was computed for each class using a training set of agents, as described by Li et al. Briefly, the standardized centroid is the mean expression level for each gene in a class divided by its within-class standard deviation. The standard centroid for each class is then shrunken toward the overall centroid to produce the nearest shrunken centroid. The method employs a shrinkage parameter that is used to control the number of features used to construct the classifier.

The shrinkage parameter was identified by employing 10-fold cross validation [@bib2]. This is done by randomly assigning samples to one of ten approximately equal-sized sets, which is also roughly balanced for the two classes. Prediction accuracy is assessed for each set with the other nine sets used to construct a classifier. From this analysis a shrinkage threshold of 2.2 produced a 65-gene panel with 100% accuracy based on 10-fold cross-validation.

2.5. Application of the TGx-28.65 signature to TK6 cells co-exposed with rat liver S9 {#s0035}
-------------------------------------------------------------------------------------

Due to revisions in the gene annotation and differences between the 4x44k and 8x60k platforms, two of the 65 genes in the TGx-28.65 biomarker were unavailable when the +S9 data were incorporated into the study. As a result, MGC5370 (due to the annotation update) and USP41 (not present on the 8x60k platform) were removed from the TGx-28.65 biomarker.

Using the remaining 63 genes, the centroids were re-estimated using the PAM.R script. This R script reads in the LogRatio.txt data into the R statistical environment. Using the training set, the pamr package was used to update the classifier. These were written to disk using the filename Classifier.txt. The summarized data are presented in [Table 1](#t0005){ref-type="table"}. Removing MGC5370 and USP41 did not impact the performance of the classifier as the accuracy remained 100% (estimated using 10-fold cross-validation).

2.6. PCA analysis {#s0040}
-----------------

A principle component analysis (PCA) was performed using the prcomp function [@bib8] in R on the training set data (Li et al. data) from the LogRatio.txt data file. Using the 63 genes in the TGx-28.65 classifier the PCA was conducted using the PCA.R script. A summary of the PCA results are presented in [Table 2](#t0010){ref-type="table"} and the scatter plot of the first two principle components for the training set are presented as [Fig. 2](#f0010){ref-type="fig"}. The red line in [Fig. 2](#f0010){ref-type="fig"} was added as the first principle component and could be interpreted as a contrast between the genotoxic (red) and non-genotoxic (blue) classes as there is a clear separation between the two classes.

The PCA loadings obtained from this analysis was applied to the +S9 data. A scatter plot of these data for the first two principle components is presented as [Fig. 3](#f0015){ref-type="fig"}. The data from the training set are represented by the red and blue circles, whereas the labels for the +S9 data are displayed with red font for the genotoxic agents and blue font for the non-genotoxic agents. For the +S9 data, the low dose samples for the genotoxic agents were displayed in gray as their genotoxicity was uncertain. Similar to [Fig. 2](#f0010){ref-type="fig"}, the genotoxic agents and non-genotoxic agents separate into two groups with the low dose genotoxic agents falling in the middle.
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Supplementary data

Supplementary data

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2015.08.013](http://dx.doi.org/10.1016/j.dib.2015.08.013){#ir0020}.

![Summary of steps taken to generate, normalize, and analyze two-color, Agilent microarray data.](gr1){#f0005}

![Scatter plot of the first and second principle component of the TGx-28.65 training set. The vertical red line indicates the first principle component at 0. The font for the genotoxic agents is red and the font for the non-genotoxic agents is blue.](gr2){#f0010}

![Scatter plot of the first and second principle component of the TGx-28.65 training set with the +S9 data. The vertical red line indicates the first principle component at 0. The genotoxic agents from the training set are represented by red circles and the non-genotoxic agents with blue circles. The font for the genotoxic agents with S9 are displayed in red font and the non-genotoxic agents with S9 are presented using the blue font.](gr3){#f0015}

###### 

TGx-28.65 classifier.

Presented are the estimated standard deviation and the shrunken centroids for the genotoxic and non-gentoxic classes.

  ID          Standard deviation   Centroids   ID       Standard deviation   Centroids            
  ----------- -------------------- ----------- -------- -------------------- ----------- -------- --------
  ACTA2       0.198                0.390       −0.330   HIST1H3D             0.244       −0.324   0.274
  AEN         0.217                0.895       −0.758   ID2                  0.275       −0.512   0.433
  ARRDC4      0.270                0.554       −0.469   IKBIP                0.198       0.625    −0.529
  B3GNT2      0.243                −0.513      0.434    ITPKC                0.170       0.460    −0.389
  BLOC1S2     0.182                0.907       −0.768   ITPR1                0.233       −0.573   0.484
  BRMS1L      0.219                0.509       −0.431   LCE1E                0.312       0.704    −0.595
  BTG2        0.207                0.854       −0.722   LRRFIP2              0.204       −0.515   0.436
  C12orf5     0.225                0.635       −0.537   MDM2                 0.197       0.807    −0.683
  CBLB        0.183                −0.617      0.522    MEX3B                0.218       0.457    −0.386
  CCP110      0.175                0.638       −0.540   NLRX1                0.208       0.469    −0.397
  CDKN1A      0.243                0.702       −0.594   PCDH8                0.259       0.829    −0.701
  CEBPD       0.328                0.502       −0.425   PHLDA3               0.211       1.026    −0.868
  CENPE       0.203                −0.546      0.462    PLK3                 0.256       0.468    −0.396
  COIL        0.273                0.425       −0.359   PPM1D                0.176       1.131    −0.957
  DAAM1       0.258                −0.570      0.482    PRKAB1               0.206       1.106    −0.936
  DCP1B       0.161                0.763       −0.646   PRKAB2               0.195       0.499    −0.422
  DDB2        0.181                0.872       −0.738   PTGER4               0.260       −0.605   0.512
  DUSP14      0.181                0.498       −0.421   RAPGEF2              0.226       −0.577   0.488
  E2F7        0.190                0.943       −0.798   RBM12B               0.182       0.521    −0.441
  E2F8        0.237                0.670       −0.567   RPS27L               0.183       0.557    −0.471
  EI24        0.174                0.545       −0.461   RRM2B                0.272       0.601    −0.508
  FAM123B     0.224                0.608       −0.514   SEL1L                0.242       −0.301   0.255
  FBXO22      0.158                0.695       −0.588   SEMG2                0.234       0.414    −0.351
  GADD45A     0.243                0.646       −0.546   SERTAD1              0.253       0.927    −0.785
  GXYLT1      0.157                0.368       −0.311   SMAD5                0.211       0.500    −0.423
  HIST1H1E    0.311                −0.471      0.398    TM7SF3               0.174       0.607    −0.514
  HIST1H2BB   0.326                −0.276      0.234    TNFRSF17             0.357       0.550    −0.466
  HIST1H2BC   0.329                −0.318      0.269    TOPORS               0.236       0.482    −0.408
  HIST1H2BG   0.349                −0.325      0.275    TP53I3               0.198       0.703    −0.595
  HIST1H2BI   0.333                −0.263      0.222    TRIAP1               0.232       0.912    −0.772
  HIST1H2BM   0.356                −0.275      0.233    TRIM22               0.234       0.847    −0.717
  HIST1H2BN   0.219                −0.218      0.185                                              

###### 

Summary of the PCA results.

The standard deviation, proportion of variance and the cumulative proportion of variance is presented for the first nine principle components. The standard deviations for the other principle components not presented were less than 1.

                           PC1      PC2      PC3       PC4       PC5       PC6       PC7       PC8       PC9
  ------------------------ -------- -------- --------- --------- --------- --------- --------- --------- ---------
  Standard deviation       5.9363   2.6398   2.23332   1.74326   1.49113   1.39276   1.16271   1.02611   1.01938
  Proportion of variance   0.5594   0.1106   0.07917   0.04824   0.03529   0.03079   0.02146   0.01671   0.01649
  Cumulative proportion    0.5594   0.6700   0.74914   0.79738   0.83267   0.86346   0.88492   0.90163   0.91813
